Publication | Closed Access
Rapamycin Inhibits the Growth and Metastatic Progression of Non-Small Cell Lung Cancer
106
Citations
26
References
2004
Year
The immunosuppressive macrolide rapamycin but not cyclosporine prevents the growth and metastatic progression of NSCLC. A rapamycin-based immunosuppressive regimen may be of value in recipients of allografts.
| Year | Citations | |
|---|---|---|
Page 1
Page 1